Bridget Kaufman is a Dermatology physician. OpenAlex indexes 24 publications with 730 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 N Franklin Tpke Ste 318
Ramsey, NJ 074461177
Telephone
201-500-7525Provider last certified this registry record 8 May 2023.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202536 payments
- Janssen Biotech, Inc.Program year202515 payments
- Regeneron Healthcare Solutions, Inc.Program year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
37.3%Corticosteroid30.4%Triamcinolone Acetonide61%Triamcinolone acetonide39%Part D + Part B≥77 patientsPolyene Antifungal6.8%Nystatin100%Part D≥23 patientsAnti-infectives
31.2%Azole Antifungal13.9%Ketoconazole100%Part D≥45 patientsLincosamide Antibacterial5.5%Clindamycin Phosphate100%Part D≥13 patients+ 3 more classes in this area
Sensory organs
15.6%Corticosteroid15.6%Clobetasol Propionate65%Hydrocortisone35%Part D≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Psoriasis in People With Skin of Color: An Evidence‐Based Update
International Journal of Dermatology
2025 - Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study
Journal of Drugs in Dermatology
2025 - Efficacy and Safety of Secukinumab in the Treatment of Psoriasis in Patients with Skin Phototypes IV to VI
Journal of Drugs in Dermatology
2024 - Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color
Journal of Drugs in Dermatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”